Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Consolidated Statements of Operations and Comprehensive Loss
Grant revenue	$ 1,502,581	$ 583,231
Operating expenses:
Research and development	9,363,537	7,627,491
General and administrative	6,458,699	8,427,703
Total operating expenses	15,822,236	16,055,194
Loss from operations	(14,319,655)	(15,471,963)
Other income (expense):
Interest income, net	1,289,144	1,224,133
Foreign currency gain (loss)	71,800	(38,926)
Total other income	1,360,944	1,185,207
Net loss	(12,958,711)	(14,286,756)
Other comprehensive (loss) income:
Foreign currency translation	(16,106)	12,135
Total comprehensive loss	$ (12,974,817)	$ (14,274,621)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (2.35)	$ (3.95)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (2.45)	$ (3.95)
Weighted-average common shares outstanding, basic (in shares)	5,509,921	3,617,607
Weighted-average common shares outstanding, diluted (in shares)	5,509,921	3,617,607